Systemic infections after acute stroke

Aging Health

Volumn 4, Issue 1, 2008, Pages 85-94

  Kwan, Joseph ^a   Jenkinson, Damian ^c   Vassallo, Mike ^c   Englyst, Nicola A ^b   Perry, V Hugh ^b  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c NONE

Author keywords

Brain; Complications; Hospital; Immunology; Infection; Stroke

Indexed keywords

AMANTADINE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; C REACTIVE PROTEIN; CILOSTAZOL; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; MINOCYCLINE; PERINDOPRIL; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC THERAPY; ASPIRATION PNEUMONIA; BACTEREMIA; BACTERIAL INFECTION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; CONSCIOUSNESS LEVEL; CYTOKINE PRODUCTION; DYSPHAGIA; FUNCTIONAL STATUS; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFECTION PREVENTION; INFECTION RISK; INFLAMMATION; NEUROPROTECTION; NONHUMAN; NOSE FEEDING; PATHOPHYSIOLOGY; PNEUMONIA; PROGNOSIS; REVIEW; TRANSIENT ISCHEMIC ATTACK; URINARY TRACT INFECTION; URINE INCONTINENCE;

EID: 39349110204     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/1745509X.4.1.85     Document Type: Review

References (122)

1. Stoll G, Bendszus M: Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37 (7), 1923-1932 (2006).
2. Ernsley HC, Tyrrell PJ: Inflammation and infection in clinical stroke. J Cereb. Blood Flow Metab. 22(12), 1399-1419 (2002).
3. Elkind MS, V, Lin I-F, Grayston JT, Sacco RL: Chlamydia pneumoniae and the risk of first ischemic stroke: the northern Manhattan stroke study. Stroke 31(7). 1521-1525 (2000).
4. Preusch MR. Grau AJ, Buggle F et al.: Association between cerebral ischemia and cytotoxin-assoclated gene-A-bearing strains of Helicobacter pylori. Stroke 35(8). 1800-1804 (2004).
5. Cremonini F, Gabrielli M, Gasbarrini G, Pola P, Gasbarrini A: The relationship between chronic H. pylori infection, CagA seropositivity and stroke: meta-analysis. Atherosclerosis 173(2), 253-259 (2004).
6. Epstein SE, Zhu J: Lack of association of infectious agents with risk of future myocardial infarction and stroke: definitive evidence disproving the Infection/coronary artery disease hypothesis? Circulation 100(13), 1366-1368 (1999).
7. Lindsberg PJ, Grau AJ: Inflammation and infections as risk factors for ischemic stroke. Stroke 34(10), 2518-2532 (2003).
8. Heuschmann PU. Neureiter D, Gesslein M et al.: Association between Infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based ease-control study. Stroke 32(10), 2253-2258 (2001).
9. Haider AW, Wilson PW, Larson MG et al.: The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective-study J. Am. Coll. Cardiol. 40(8), 1408-1413. (2002).
10. Wakugawa Y, Kiyohara T, Tanizaki Y. et al.: C-reactive protein and risk of first ever ischemic and hemorrhagic stjoke in a general Japanese population: the Hisayama Study. Stroke 37(1), 27-32 (2006).
11. Rost NS, Wolf PA, Kase CS et al.: Plasma concentration of C-reactive protein and risk of Ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2(11), 2575-2579 (2001).
12. Cao JJ,Thach C. Manolio TA et al.: C-reactive protein, carotid intima-media thickness, and incidence of Ischemie stroke in the elderly: the cardiovascular health study. Circulation 108(2), 166-170 (2003).
13. Wang Q, Hunt SC, Xu Q et al.: Association study of CRP gene polymorphisms with serum CRP level and cardiovascular risk in the NHLBI Family Heart Study. Am. J Physiol. Heart Circ. Physiol. 291(6), H2752-H2757 (2006).
14. Di Napoli M, Papa F. Bocola V: C-reactive protein in ischernic stroke: an independent prognostic factor. Stroke 32(4), 917-924 (2001).
15. Johnston KC, Li JY, Lyden PD et al.: Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. Stroke 29(2), 447-453 (1998).
16. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B et al.: Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch. Intern. Med. 164(16), 1761-1768 (2004).
17. Langhorne P, Stott DJ, Robertson L et al.: Medical complication after stroke: a multicenter study: Stroke 31(6). 1223-1229 (2000).
18. Chamorro A, Horcajada JP, Obach V et al.: The early systemic prophylaxis of infection after stroke study: a randomized clinical trial. Stroke 36(7), 1495-1500 (2005).
19. Dromerick A, Reding MJ: Medical and neurological complications during inpatient stroke rehabilitation. Stroke 25, 358-361 (1994).
20. Vargas M. Horcajada JP, Obach V et al.: Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke 37(2), 461-465 (2006).
21. Davenport RJ, Dennis M, Wenwood I; Warlow C: Complicationss after acute stroke. Stroke 27, 415-420 (1996).
22. Georgilis K, Plomaritoglou A. Dafni U. Bassiakos, Y, Vemmos K: Aetiology of fever in patients with acute stroke. J. Intern. Med. 246(2), 203-209 (1999).
23. Weimar C, Roth MP, Zillessen G et al.: Complications following acute ischemic stroke. Eur. Eur. Nuerol. 48(3), 133-140 (2002).
24. Aslanyan S, Weir CJ, Diener HC, Kaste M. Lees KR: Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur. J. Neurol. 11(1). 49-53 (2004).
25. Grau AJ, Buggie F, Schnitzier P et al.: Fever and infection early after ischemic stroke. J. Neurol. Sci. 171(2), 115-120 (1999).
26. Kaira L, Yu G. Wilson K, Roots P: Medical complications during stroke rehabilitation. Stroke 26(6), 990-994 (1995).
27. Roth EJ, Lovell L, Harvey RL et al.: Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke 32(2), 523-529 (2001).
28. Dromerick AW, Edwards DF: Relation of postvoid residual to urinary tract infection during stroke rehabilitation. Arch. Phys. Med. Rehabil. 84(9), 1369-1372 (2003).
29. Kwan J, Hand P: Infection after acute stroke is associated with poor short-term outcome. Acta Neurol. Scand. 115(5), 331-338 (2007).
30. Katzan IL, Dawson NV, Thomas CL. Votruba ME, Cebul RD: The cost of pneumonia after acute stroke. Neurology 68(22). 1938-1943 (2007).
31. Erson M, Ulusoy H, Oktar MA, Akyuz M: Urinary tract infection and bacteriurua in stroke patients.: frequencies, pathogen microorganisms, and risk factors. Am. J. Phys. Med. Rehabil. 86(9), 734-741 (2007).
32. Graves N, Nicholis TM, Wong CG, Morris AJ: The prevalence and estimates of the cumulative incidence of hospital-acquired infections among patients admitted to Auckland District Health Board Hospitals in New Zealand. Infect. Controi Hasp. Epidemiol. 24(1), 56-61 (2003).
33. Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC Jr: Depressed interferon γ production and monocyte HLA-DR expression after severe injury. Arch. Surg. 123(11), 1309-1312 (1988).
34. Woiciechowsky C, Schoning B, Daberkow N et al.: Brain-IL-1β induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamic-pituitary-adrenal axis and sympathetic nervous system. Brain Res. 816(2), 563-571 (1999).
35. Nguyen-Van-Tam SE, Nguyen-Van-Tam JS, Myint S, Pearson JC: Risk factors for hospital-acquired urinary tract infection in a large English teaching hospital: a case-control study. Infection 27(3), 192-197 (1999).
36. Hussain M. Oppenheim,BA, O'Neill P et al.: Prospective survey of the incidence, risk factors and outcome of hospital-acquired infections in the elderly. J Hosp. Infect. 32(2), 117-126 (1996).
37. Doggett DL, Tappe KA, Mitchell MD et al.: Prevention of pneumonia in elderly stroke patients by systematic diagnosis and treatment of dysphagia: an evidence-based comprehensive analysis of the literature. Dysphagia 16(4), 279-295 (2001).
38. Martino R, Foley N, Bhogal S et al.: Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 36(12), 2756-2763 (2005).
39. Marik PE: Aspiration pneumonitis and aspiration pneumonia. N. Engl. J. Med. 344(9), 665-671 (2001).
40. Widdicombe J, Singh V: Physiological and pathophysiological down-regulation of cough. Respir. Physiol. Neurobiol. 150(2-3), 105-117 (2006).
41. Dziewas R. Ritter M, Schilling M et al.: Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol. Aeurosurg. Psychiatry 75(6), 852-856 (2004).
42. Werner GT. Gadomski M, Scheinert B: The significance of urinary tract infections in patients with cerebrovascular diseases. during clinical rehabilitation. Rehabilitation (Stuttg.) 37(2), 64-67 (1998).
43. Roth EJ, Lovell L, Harvey RL, Bode RK, Heinemann AW: Stroke rehabilitation: Indwelling urinary catheters, enteral feeding tubes, and tracheostomies are associated with resource use and functional outcomes. Stroke 33(7), 1845-1850 (2002).
44. Kwan J, Hand P, Sandercock PA, Dennis MS: What are the consequendes of urinary catheterisation in patients with acute stroke? Cerebrovasc. Dis. 16(Suppl. 4), 26 (2003).
45. Johnson JR, Kuskowski MA, Wilt TJ: Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann. Intern. Med. 144(2), 116-126 (2006).
46. FOOD Trial Collaboration: Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the FOOD trial. Stroke 34(6), 1450-1456 (2003).
47. Weimar C, Ziegler A, Konig IR, Diener HC: Predicting functional outcome and survival after acute Ischemic stroke. J. Neurol. 249(7), 888-895 (2002).
48. Hilker R, Poetter C, Findeisen N et al.: Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 34(4), 975-981 (2003).
49. Hamidon BB, Raymond AA, Norlinah MI, Jefferelli SB: The predictors of early Infection after an acute ischaemic stroke. Singapore Med. J. 44(7), 344-346 (2003).
50. Upadya A, Thorevska N, Sena KN, Manthous C, Moateng-Adjepong Y: Predictors and consequences of pneumonia in critically ill patients with stroke. J Crit. Care 19(1), 16-22 (2004).
51. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW: The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 60(4), 620-625 (2003).
52. Sellars C, Bowie L, Bagg J et al.: Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke 38(8), 2284-2291 (2007).
53. Dziedzic T, Slowik A, Pera J, Szczudlik A: β-blockers reduce the risk of early death in ischemic stroke. J. Neurol. Sci. 252(1), 53-56 (2007).
54. Smith CJ, Emsley HC, Vail A et al.: Variability of the systemic acute phase respose after ischemic stroke. J. Neurol. Sci. 251(1-2), 77-81 (2006).
55. Texereau J, Pene F, Chiche JD, Rousseau C, Mira JP: Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis. Crit. Care Med. 32(Suppl. 5), S313-S319 (2004).
56. Schulte-Herbruggen O, Klehmet J, Quarcoo D, Meisel C, Meisel A: Mouse strains differ in their susceptibility to poststroke infections. Neuroimmunomodulation 13(1), 13-18 (2006).
57. Holmes CL, Russell JA, Walley KR: Genetic polymorphisms in sepsis and septic shock: role in prgnosis and potential for therapy. Chest 124(3), 1103-1115 (2003).
58. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U: Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 6(10), 775-786 (2005).
59. Woiciechowsky C, Schoning B, Lanksch WR, Volk HD, Docke WD: Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J. Mol. Med. 77(11), 769-780 (1999).
60. Prass K, Meisel C, Hoflich C et al.: Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 198(5), 725-736 (2003).
61. Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A: Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 37 (10), 2607-2612 (2006).
62. Dirnagl U, Klehmet J, Braun JS et al.: Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 38 (Suppl. 2), 770-773 (2007).
63. Chamorro A, Urra X, Planas AM: Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38(3), 1097-1103 (2007).
64. Czlonkowska A, Korlak J: The immune response during aging. J. Gerontol. 34(1), 9-14 (1979).
65. Haeusler KG, Schmidt WU, Fohring F et al.: Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc. Dis. 25(1-2). 50-58 (2007).
66. Kammersgaard LP, Jorgensen HS, Reith J et al.: Early infection and prognosis after acute stroke: the Copenhagen Stroke Study. J. Cereb. Blood Flow Metab. 10(5), 217-221 (2001).
67. Henon H, Godefroy O, Leys D et al.: Early predictors of death and disability after acute cerebral ischemic event. Stroke 26(3), 392-398 (1995).
68. Viitanen M, Winblad B, Asplund K: Autopsy-verified causes of death after stroke. Acta Med. Scand. 222(5), 401-408 (1987).
69. Daud-Gallotti R, Dutilh Novaes HM, Lorenzi MC et al.: Adverse events and death in stroke patients admitted to the emergency department of a tertiary university hospital. Eur. J. Emerg. Med. 12(2), 63-71 (2005).
70. Vernino S, Brown RD Jr, Sejvar JJ et al.: Cause-specific mortality after first cerebral infarction: a population-based study. Sroke 34(8), 1828-1832 (2003).
71. Castillo J, Davalos A. Noya M: Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 349(9045), 79-83 (1997).
72. Greenberg JH: Glucose and oxygen metabolism in ischaemia. In: Cerebrovascular Disease. Pathophysiology, Diagnosis, and Management. Ginsberg MD, Bogousslavsky J (Eds). Maiden Blackwell Science, MA, USA (1998).
73. Busto R, Ginsberg MD: The influence of altered brain temperature in cerebral ischaemia. In: Cerebrovascular Disease. Pathophysiology, Diagnosis, and Management. Ginsberg MD, Bogousslavsky J (Eds). Malden Blackwell Science, MA, USA (1998).
74. Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ: Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke 35(6), 1421-1425 (2004).
75. Audebert HJ, Pellkofer TS, Wimmer ML, Haberl RL: Progression in lacunar stroke is related to elevated acute phase parameters. Eur. Nerol. 51(3), 125-131 (2004).
76. Ashare A, Powers LS, Butler NS et al.: Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am. J. Physiol. Lung Cell Mol. Physiol. 288(4), L633-L640 (2005).
77. Hajat C, Hajat S, Sharma P: Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 31(2), 410-414 (2000).
78. Dippel DWJ, van Breda EJ, van Gemert HMA et al.: Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: a double-blind, randomized Phase II clinical trial. Stroke 32(7), 1607-1612 (2001).
79. Reglodi D, Somogyvari-Vigh A, Maderdrut JL, Vigh S, Arimura A: Postischemic spontaneous hyperthermia and its effects in middle cerebral artery occlusion in the rat. Exp. Neurol. 163(2), 399-407 (2000).
80. Coimbra C, Drake M, Boris-Moller F, Wieloch T: Long-lasting neuroprotective effect of postischemic hypothemia and treatment with an anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic processes following ischemia. Stroke 27(9), 1578-1585 (1996).
81. Schmid-Elsaesser R, Hungerhuber E, Zausinger S, Baethmann A, Reulen HJ: Combination drug therapy and mild hypothermia: a promising treatment strategy for reversible, focal cerebral ischemia. Stroke 30(9), 1891-1899 (1999).
82. Emsley HC, Smith CJ, Gavin CM et al.: An early and sustained peripheral-inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J. Neuroimmunol. 139(1-2), 93-101 (2003).
83. Arenillas JF, varez-Sabin J, Molina CA et al.: C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 34 (10), 2463-2468 (2003).
84. Di Napoli M, Papa F, Bocola V: C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32(4), 917-924 (2001).
85. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR: C-reactive protein and outcome after ischemic stroke. Stroke 30(5), 981-985 (1999).
86. Montaner J, Fernandez-Cadenas I, Molina CA et al.: Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke 37(5), 1205-1210 (2006).
87. del Zoppo GJ, Becker KJ, Hallenbeck JM: Inflammation after stroke: is it harmful? Arch. Neurol.58(4), 669-672 (2001).
88. Feuerstein GZ, Wang X: Inflammation and stroke: benefits without harm? Arch. Neurol.58(4), 672-674 (2001).
89. Engiyst N, Kwan J, Horsfield G, Bryant T, Gawne-Cain M, Byrne C: Infection and IL-6 are independent risk factors for a poor functional outcome from ischaemic stroke. Cerebrovasc. Dis. 23(Suppl. 2), 64 (2007).
90. Montero I, Orbe J, Varo N et al.: C-reactive protein induces matrix metalloproteinase-1 and -10 in human endopthetial cells: implications for clinical and subclinical atherosclerosis. J. Am. Coll. Cardiol. 47(7). 1369-1378 (2006).
91. Woollard KJ, Phillips DC, Griffiths HR: Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endthelial cells. Clin. Exp. Immunol. 130(2), 256-262 (2002).
92. Gee JM, Kalil A. Shea C, Becker KJ: Lymphocytes: potential mediators of postischemic injury and neuroprotection. Stroke 38(Suppl. 2), 783-788 (2007).
93. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH: Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25(40), 9275-9284 (2005).
94. Perry VH: Stress primes microglia to the presence of systemic inflammation: implications for environmental influenoes on the brain. Brain Behav. Immun. 21(1), 45-46 (2007).
95. Emsley HC, Smith CJ, Georgiou RF et al.: A randomised Phase II study of interieukin-1 peceptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psychiatry 76(10), 1366-1372 (2005).
96. Enlimomab Acute Stroke Trial Investigators: Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 57(8), 1428-1434 (2001).
97. Fassbender K, Dempfie CE, Mielke O et al.: Proinflammatory cytokines: indicators of infection in high-risk patients. J. Lab. Clin. Med. 130(5), 535-539 (1997).
98. Govan L, Langhorne P, Weir CJ: Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care?: further analysis of a systematic review. Stroke 38(9), 2536-2540 (2007).
99. Evans A, Perez I, Harraf F et al.: Can differences in management processes explain different outcomes between stroke unit and stroke-team care? Lancet 358(9293), 1586-1592 (2002).
100. Hack W, Kaste M, Bogousslavsky J et al.: European Stroke Initiative Recommendations for Stroke Management - update 2003. Cerebrovasc. Dis. 16(4), 311-337 (2003).
101. Reith J, Jorgensen HS. Pedersen PM et al.: Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347(8999), 422-425 (1996).
102. Oconnor E, Venkatesh B, Mashongonyika C et al.: Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage. Anaesth. Intensive Care 32(4), 465-470 (2004).
103. Gattas DJ, Cook DJ: Procalcitonin as a diagnostic test for sepsis: health technology assessment in the ICU. J. Crit. Care 18(1), 52-58 (2003).
104. Miyakis S, Georgakopoulos P, Kiagia M et al.: Serial serum procalcitonin changes in the prognosis of acute stroke. Clin. Chim. Acta 350(1-2), 237-239 (2004).
105. Schlosser HG, Volk HD, Splettstosser G, Brock M. Wolclechowsky C: A new qualitative interleukin-6 bedside test can predict pneumonia in patients with severe head injury - comparison to the standard Immulite test and a semiquantitative bedside test. J. Neurosurg. Anesthesiol. 19(1), 5-9 (2007).
106. Meisel C, Prass K. Braun J et al.: Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 35(l), 2-6 (2004).
107. Shinohara Y. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. Cerebrovacs. Dis. 22(l), 57-60 (2006).
108. Teramoto S, Yamamoto H, Yamaguchi Y et al.: ACE inhibitors prevent aspiration pneumonia in Asian, but not Caucasian elderly patients with stroke. Eur. Respir. J. 29(l), 218-219 (2007).
109. Arai T, Sekizawa K, Ohrui T et al.: ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology 64(3), 573-574 (2005).
110. Harada J, Sekizawa K: Angiotensin-converting enzyme inhibitors and pneumonia in elderly patients with Intracerebral hemorrhage. J. Am. Geriatr. Soc. 54(l), 175-176 (2006).
111. Ohkubio T, Chapman N, Neal B et al.: Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am. J. Respir. Crit. Care Med. 169(9), 1041-1045 (2004).
112. Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H: ACE inhibitors and pneumonia. Lancet 352(9133), 1069 (1998).
113. Nakagawa T, Wada H, Sekizawa K, Arai H, Sasaki H: Amantadine and pneumonia. Lancet 353(9159), 1157 (1999).
114. Yrjanheikki J, Keinanen R, Peilikka M, Hokfelt T, Koistinaho J: Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad. Sci. USA 95(26), 15769-15774 (1998).
115. Yrjanheikki J, Tikka T, Keinanen R et al.: A tetracycline derivative minocycline, reduces Inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl Acad. Sci. USA 96(23), 13496-13600 (1999).
116. Zemke D, Majid A: The potential of minocycline for neuroprotection in human neurologic disease. Clin. Neuropharmacol. 27(6), 293-298 (2004).
117. Rothstein JD, Patel S, Regan MR et al.: β-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433(7021), 73-77 (2005).
118. Kwan, J, Englyst, N, Roberts, HC. Do we really understand the pathophysiology and clinical impact of post-stroke infection? Stroke 37, 1656 (2006).
119. Nakajoh K, Nakagawa T, Sekizawa K et al.: Relation between incidence of pneumonia and protective reflexes in post-stroke patients with oral or tube feeding. J. Intern. Med. 247(l), 30-42 (2000).
120. Rowat AM, Wardlaw JM, Dennis MS, Warlow CP: Patient positioning influences oxygen saturation in the acute phase of stroke. Cerbrovasc. Dis. 12(1), 66-72 (2001).
121. Stensballe J. Tvede M, Looms D et al.: Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Ann. Intern. Med. 147(5), 285-293 (2007).
122. Niel-Weise BS, van den Broek PJ: Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst. Rev. (3), CD004203 (2005).